ARCHIVES

Trials show No Advantage for ABMT In Breast Cancer; Should Insurers Pay?

This article is from The Cancer Letter archive.

Vol. 25 No. 15 | April 16, 1999

Download PDF Visit The Full Archive

Related Articles

Combination Radiation/Vaccine May Benefit Some Patients

April 29, 2005

Bushes Restate Commitment to Dialogue

August 8, 2003

Wyden, Schroeder Bill Would Require NIH To Test RU 486

October 23, 1992

FDA Proposes To Drop Specific Requirements For Reprint Distribution On Off-Label Uses.

February 22, 2008

Revised Price Equivalent to Lower Dose of Avastin

November 8, 2012

ACS to Being Review Of Facilities Survey Proposals; Working Group Established

May 25, 1984